Navigation Links
NASA, CASIS Make Space Station Accessible for Stem Cell Research
Date:12/6/2013

WASHINGTON, Dec. 6, 2013 /PRNewswire-USNewswire/ -- NASA and the Center for the Advancement of Science in Space (CASIS) are enabling research aboard the International Space Station that could lead to new stem cell-based therapies for medical conditions faced on Earth and in space.

(Logo: http://photos.prnewswire.com/prnh/20081007/38461LOGO)

Scientists will take advantage of the space station's microgravity environment to study the properties of non-embryonic stem cells.

NASA is interested in space-based cell research because it is seeking ways to combat the negative health effects astronauts face in microgravity, including bone loss and muscle atrophy. Mitigation techniques are necessary to allow humans to push the boundaries of space exploration far into the solar system. This knowledge could help people on Earth, particularly the elderly, who are afflicted with similar conditions.

Two stem cell investigations scheduled to fly to the space station next year were highlighted Friday, Dec. 6, at the World Stem Cell Summit in San Diego. Lee Hood, a member of the CASIS Board of Directors, moderated a panel session in which scientists Mary Kearns-Jonker of Loma Linda University in California and Roland Kaunas of Texas A&M University discussed their planned research, which will gauge the impact of microgravity on fundamental stem cell properties.

Kearns-Jonker's research will study the aging of neonatal and adult cardiac stem cells in microgravity with the ultimate goal of improving cardiac cell therapy. Kaunas is a part of a team of researchers developing a system for co-culturing and analyzing stem cells mixed with bone tumor cells in microgravity. This system will allow researchers to identify potential molecular targets for drugs specific to certain types of cancer.

Stem cells are cells that have not yet become specialized in their functions. They display a remarkable ability to give rise to a spectrum of cell types and ensure life-long tissue rejuvenation and regeneration. Experiments on Earth and in space have shown that microgravity induces changes in the way stem cells grow, divide and specialize. Stem cell biology in microgravity could inform fields ranging from discovery science to tissue engineering to regenerative medicine.

NASA selected CASIS to maximize use of the International Space Station's U.S. National Laboratory through 2020. CASIS is dedicated to supporting and accelerating innovations and new discoveries that will enhance the health and wellbeing of people and our planet.

For more information about the International Space Station, visit:

http://www.nasa.gov/station

For more information about CASIS, visit:

http://www.iss-casis.org


'/>"/>
SOURCE NASA
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. BioSpace Spotlights Northwests Life Science Community
2. BioSpace Spotlights Leading Life Science Community
3. Saladax Biomedical, Inc. Issued Six Patents Containing Broad Claims in the Immunoassay Space
4. Space Research Institute Honors Senator Hutchison with Pioneer Award
5. framergyTM to partner with the Space Alliance Technology Outreach Program
6. The future of aerospace takes off in Montreal
7. Webinar Announcement: GenomeSpace: A New Solution for Integrating Genomic Analysis Tools
8. BioSpace Promotes the Northeast Corridors Life Science Industry
9. Research paves the way for accurate manufacturing of complex parts for aerospace and car industries
10. GenoSpace Announces the Launch of a Cloud-Based "Information Ecosystem" for Advancing 21st-Century Personalized Medicine
11. United States Rocket Academy Welcomes XCOR Aerospace to Texas
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... 2017 /PRNewswire/ - FACIT announced a seed stage ... a start-up created by FACIT focused on developing ... combined with non-dilutive capital, achieves a targeted $3.0M ... enables Propellon to accelerate the nomination of a ... and/or entering a strategic partnership for clinical trials ...
(Date:3/22/2017)... Yorba Linda, Ca (PRWEB) , ... March 21, ... ... immunogenicity, and clearance of biologics. To acquire information on the desired increase and/or ... in the biopharmaceutical industry for rapid N-glycosylation profiling of therapeutic antibodies. , ...
(Date:3/22/2017)... ... March 21, 2017 , ... Functional near-infrared spectroscopy (fNIRS), ... being explored as a way to track the brain’s response to acute pain in ... by cold pressor test ,” published today in the journal Neurophotonics , by ...
(Date:3/22/2017)... , March 22, 2017  RXi Pharmaceuticals Corporation ... therapeutics that address significant unmet medical needs, today ... Business Officer, will present at the 5th Annual ... provide a platform to present to and meet ... pharmaceutical and biotech companies as well as institutional ...
Breaking Biology Technology:
(Date:3/9/2017)... and MOUNTAIN VIEW, Calif. , ... Well Made Simple," and 23andMe , the leading ... better food choices.  Zipongo can now provide customers with ... preferences, health goals and biometrics, but also genetic markers ... choices. Zipongo,s personalized food decision support platform ...
(Date:3/2/2017)... YORK , March 2, 2017 Summary ... better understand Perrigo and its partnering interests and activities since ... ... Partnering Deals and Alliance since 2010 report provides an in-depth ... leading life sciences companies. On demand company reports ...
(Date:3/1/2017)... BEDFORD, Mass. , March 1, 2017  Aware, ... and services, announced that Richard P. Moberg ... Officer and co-President and Chief Financial Officer and Treasurer ... will continue to serve as a member of the ... T. Russell , Aware,s co-Chief Executive Officer and co-President, ...
Breaking Biology News(10 mins):